PETER AND THOMAS INC. proudly presents to you:

“NEW THERAPEUTIC INTERVENTIONS IN 21ST CENTURY”


ABCIXIMAB – GP IIb/IIIa antagonist – prior or during PTCA

TRANSTUZUMAB – HER-2 positive breast cancer

PALIVIZUMAB – RSV prophylaxis in children

IMATINIB – chronic myeloid leukaemia

IRESSA (gefitinib) – metastatic lung cancer

BETA-INTERFERON – relapsing-remitting multiple sclerosis

ALPHA-INTERFERON – active Hepatitis C infection

INFLIXIMAB – relapsing Crohn’s disease, RA

ETANERCEPT – psoriasis, RA

ALEMTUZUMAB – chemotherapy resistant chronic lymphocytic leukaemia

RITUXIMAB – large B-cell non-Hodgkin lymphoma